Evidence map›Paper›PMID 34456901›Full record

ArticleFrontiers in immunology2021

TLR-9 Plays a Role in

André Alves Dias, Carlos Adriano de Matos E Silva, Camila Oliveira da Silva, Natasha Ribeiro Cardoso Linhares, João Pedro Sousa Santos, Aislan de Carvalho Vivarini, Maria Ângela de Mello Marques, Patrícia Sammarco Rosa, Ulisses Gazos Lopes, Márcia Berrêdo-Pinho and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

André Alves DiasLaboratory of Cellular Microbiology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Carlos Adriano de Matos E SilvaLaboratory of Cellular Microbiology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Camila Oliveira da SilvaLaboratory of Cellular Microbiology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Natasha Ribeiro Cardoso LinharesLaboratory of Cellular Microbiology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
João Pedro Sousa SantosLaboratory of Cellular Microbiology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Aislan de Carvalho VivariniLaboratory of Molecular Parasitology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Maria Ângela de Mello MarquesMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University (CSU), Fort Collins, CO, United States.
Patrícia Sammarco RosaDivision of Research and Teaching, Lauro de Souza Lima Institute, Bauru, Brazil.
Ulisses Gazos LopesLaboratory of Molecular Parasitology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Márcia Berrêdo-PinhoLaboratory of Cellular Microbiology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Maria Cristina Vidal PessolaniLaboratory of Cellular Microbiology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Fundação Oswaldo Cruz · BRUniversidade Federal do Rio de Janeiro · BRColorado State University · USInstituto Lauro de Souza Lima · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The respiratory tract is considered the main port of entry of

Indexed as

Immunity, InnateA549 CellsAlveolar Epithelial CellsBiomarkersCells, CulturedHistonesHost-Pathogen InteractionsHumansImmunomodulationLeprosyMycobacterium lepraeNF-kappa BToll-Like Receptor 9BiomarkersHistonesNF-kappa BToll-Like Receptor 9chemokinesextracellular DNAhistone-like protein (Hlp)innate immune responseMycobacterium lepraerespiratory epithelial cellsToll-like receptor 9 (TLR-9)

Identifiers

PMID34456901
PMCPMC8397448
OpenAlexW3195426181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.